These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Selective neuronal degeneration in Huntington's disease. Cowan CM; Raymond LA Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809 [TBL] [Abstract][Full Text] [Related]
8. Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation. Hersch SM Curr Opin Neurol; 2003 Aug; 16(4):501-6. PubMed ID: 12869810 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms of neurodegeneration in Huntington's disease. Lee J; Hwang YJ; Kim KY; Kowall NW; Ryu H Neurotherapeutics; 2013 Oct; 10(4):664-76. PubMed ID: 24006238 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Roze E; Saudou F; Caboche J Curr Opin Neurol; 2008 Aug; 21(4):497-503. PubMed ID: 18607213 [TBL] [Abstract][Full Text] [Related]
11. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Milnerwood AJ; Raymond LA Trends Neurosci; 2010 Nov; 33(11):513-23. PubMed ID: 20850189 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench. Rosenstock TR; Duarte AI; Rego AC Curr Drug Targets; 2010 Oct; 11(10):1218-36. PubMed ID: 20840066 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs in Huntington's disease neurodegeneration. Johnson R Neurobiol Dis; 2012 May; 46(2):245-54. PubMed ID: 22202438 [TBL] [Abstract][Full Text] [Related]
14. [Current perspectives in the treatment of Huntington's chorea]. Kuran W Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges]. Bantubungi K; Blum D Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808 [TBL] [Abstract][Full Text] [Related]
18. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease. Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809 [TBL] [Abstract][Full Text] [Related]
19. [The role of mitochondria in the pathogenesis of Huntington's disease]. Karachitos A; Gałgańska H; Kmita H Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112 [TBL] [Abstract][Full Text] [Related]
20. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Gil JM; Rego AC Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]